Horizon Discovery Licenses CRISPR-Cas9 Technology | GenomeWeb

NEW YORK (GenomeWeb) – Horizon Discovery today announced it has licensed technology from ERS Genomics related to the CRISRP-Cas9 gene editing system.

Under the terms of the non-exclusive agreement, Horizon can use the technology for research applications, such as the development and sale of research tools, kits, and reagents; performance of research services; development of genetically modified disease model cell lines; development and production of reference standard materials for molecular diagnostics; and internal target identification and validation research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: certain genes repressed during memory formation, analysis of genomes from single neurons, and more.

NASA plans to test whether DNA sequencing studies can be conducted in microgravity.

Congress passes a continuing resolution to keep the US federal government funded through mid-December.

The Human Genome Project was launched 25 years ago, and at Nature, Francis Collins, James Watson, and Eric Green look back at the lessons learned.